B
BioXcel Therapeutics, Inc. Common StockBTAI
BioXcel Therapeutics, Inc. (Nasdaq: BTAI) is a biopharmaceutical company built on artificial intelligence ('AI') to develop transformative medicines in neuroscience. Its wholly owned subsidiary, OnkosXcel Therapeutics, is focused on the development of medicines in.
US StocksHealthcareSmall CapArtificial IntelligenceBiotechnologyGrowth Stocks
BTAI の価格トレンド
BioXcel Therapeutics, Inc. Common Stock · TradingView フルチャート
NASDAQ:BTAI